NO951768L - Fremgangsmåte for fremstilling av monoklonale menneske-antistoffer som er aktive mot Hepatit B-overflateantigen - Google Patents

Fremgangsmåte for fremstilling av monoklonale menneske-antistoffer som er aktive mot Hepatit B-overflateantigen

Info

Publication number
NO951768L
NO951768L NO951768A NO951768A NO951768L NO 951768 L NO951768 L NO 951768L NO 951768 A NO951768 A NO 951768A NO 951768 A NO951768 A NO 951768A NO 951768 L NO951768 L NO 951768L
Authority
NO
Norway
Prior art keywords
monoclonal antibodies
preparation
human monoclonal
surface antigen
active against
Prior art date
Application number
NO951768A
Other languages
English (en)
Other versions
NO951768D0 (no
Inventor
Lars Ostberg
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NO951768D0 publication Critical patent/NO951768D0/no
Publication of NO951768L publication Critical patent/NO951768L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Monoklonale antistoffer som er effektive for diagnose og behandling av hepatitt B, er fremstilt fra en cellelinje oppnådd ved å smelte sammen et xenogent hybrid med betegnelsen SPAZ 4 og blodceller fra en pasient som er immunisert med hepatitt B-vaksine.
NO951768A 1992-11-06 1995-05-05 Fremgangsmåte for fremstilling av monoklonale menneske-antistoffer som er aktive mot Hepatit B-overflateantigen NO951768L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HU9501328A HUT72546A (en) 1992-11-06 1992-11-06 Production of human monoclonal antibodies active against hepatitis b surface antigen
CZ951164A CZ116495A3 (en) 1992-11-06 1992-11-06 Production of human monoclonal antibodies against hepatitis b surface antigen
CA002147600A CA2147600A1 (en) 1992-11-06 1992-11-06 Production of human monoclonal antibodies active against hepatitis b surface antigen
PCT/US1992/009749 WO1994011495A1 (en) 1992-11-06 1992-11-06 Production of human monoclonal antibodies active against hepatitis b surface antigen

Publications (2)

Publication Number Publication Date
NO951768D0 NO951768D0 (no) 1995-05-05
NO951768L true NO951768L (no) 1995-06-19

Family

ID=27427228

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951768A NO951768L (no) 1992-11-06 1995-05-05 Fremgangsmåte for fremstilling av monoklonale menneske-antistoffer som er aktive mot Hepatit B-overflateantigen

Country Status (7)

Country Link
AU (1) AU684455B2 (no)
CA (1) CA2147600A1 (no)
CZ (1) CZ116495A3 (no)
FI (1) FI952171A (no)
HU (1) HUT72546A (no)
NO (1) NO951768L (no)
WO (1) WO1994011495A1 (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0698042A1 (en) * 1993-05-10 1996-02-28 Stichting Centraal Laboratorium van de Bloedtransfusiedienst van het Nederlandse Rode Kruis Composition of antibodies against hepatitis b surface antigen
IL118625A0 (en) * 1996-06-11 1996-10-16 Xtl Biopharmaceuticals Limited Anti HBV antibodies
IL118626A0 (en) * 1996-06-11 1996-10-16 Xtl Biopharmaceuticals Limited Anti HBV antibody
EP0852951A1 (de) 1996-11-19 1998-07-15 Roche Diagnostics GmbH Stabile lyophilisierte pharmazeutische Zubereitungen von mono- oder polyklonalen Antikörpern
EP0893124A1 (de) * 1997-07-24 1999-01-27 Roche Diagnostics GmbH Pharmzeutische Kombinationspräparate enthaltend humane monoklonale Antikörper zur Behandlung der chronischen Hepatitis B und eine Virostatisch wirksame Substanz
JP4772199B2 (ja) * 2000-03-31 2011-09-14 オーソ−クリニカル・ダイアグノスティックス・インコーポレイテッド 新規なｂ型肝炎ウイルス
WO2013165972A2 (en) * 2012-04-30 2013-11-07 Cell Signaling Technology, Inc. Anti-hepatitis b virus antibodies and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346073A (en) * 1980-04-11 1982-08-24 The United States Of America As Represented By The Department Of Health And Human Services Hepatitis B immune globulin used to inactivate hepatitis B virus in injectable biological products
CH652145A5 (de) * 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.

Also Published As

Publication number Publication date
AU3177593A (en) 1994-06-08
CZ116495A3 (en) 1996-05-15
FI952171A (fi) 1995-07-05
HUT72546A (en) 1996-05-28
CA2147600A1 (en) 1994-05-26
FI952171A0 (fi) 1995-05-05
WO1994011495A1 (en) 1994-05-26
AU684455B2 (en) 1997-12-18
HU9501328D0 (en) 1995-06-28
NO951768D0 (no) 1995-05-05

Similar Documents

Publication Publication Date Title
IL59919A0 (en) A monoclonal antibody of class lgg,its preparation and pharmaceutical compositions containing it
ATE13198T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches t-zellenantigen, antikoerper und verfahren.
EP1978033A3 (en) Human antibodies derived from immunized xenomice
ATE13317T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches prothymozytantigen; antikoerper und verfahren zu seiner herstellung; diagnostische und therapeutische verwendungen und diesen antikoerper enthaltende pharmazeutische zusammensetzungen.
DK154091C (da) Fremgangsmaade til fremstilling af et monoklonalt antistof samt fremgangsmaade til diagnose hermed og diagnostisk praeparat indeholdende antistoffet
EP0584715A3 (de) Gewinnung und Kultivierung transformierter Zellen und Herstellung gegen sie gerichteter Antikörper.
CA2037105A1 (en) Diagnostic assay for alzheimer's disease
NO951768L (no) Fremgangsmåte for fremstilling av monoklonale menneske-antistoffer som er aktive mot Hepatit B-overflateantigen
GB8609058D0 (en) Monoclonal antibodies
DK154090C (da) Fremgangsmaade til fremstilling af et monoklonalt antistof, hybridomacellelinie til anvendelse ved fremgangsmaaden samt fremgangsmaade til diagnose under anvendelse af det fremstillede monoklonale antistof
Wierzchowiecki et al. Immunoglobulin deposits in skin in systemic lupus erythematosus
Collins et al. A naturally occurring monospecific anti‐HL‐A8 isoantibody
DK172686A (da) Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet
DE3854267D1 (de) HIV-spezifische monoklonale Antikörper und Hybridome zu ihrer Herstellung.
IE880976L (en) Human tumour-associated antigen
JPS6463392A (en) Monoclonal antibody against specific antigen for human immunodeficiency virus
ES2000615A6 (es) Procedimiento para la preparacion del anticuerpo monoclonal designado como mak 436-15 del isotipo igg3"
IL95457A (en) Preparations containing immunoconjugates for detection and treatment of infections
DE3272729D1 (en) Hepatitis-a viruses adapted to human fibroblast cells
IL86958A0 (en) Human monoclonal antibody igm 16-88,cell lines producing it and antigen recognized thereby
NO883603D0 (no) Humane monoklonale antistoffer og profylaktiske og terapeutiske midler mot infektioese sykdommer inneholdende disse som effektiv bestanddel.
ATE207119T1 (de) Die herstellung von menschlichen, monoklonalen antikörpern, die gegen das oberflächenantigen von hepatitis b aktiv sind
DE68918127D1 (de) Peptidbehandlung von hartnäckigen Infektionskrankheiten.
Prather et al. Reversal of SV40 tumor-mediated suppression of spleen cell cytotoxicity by antibody
WO1999045969A3 (de) Radioimmunpharmakon zur behandlung der hiv-1-infektion

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application